Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Breast Cancer”

531 trials

Showing 20 of 531 results

Early research (Phase 1)Ended earlyNCT03816839
What this trial is testing

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Who this might be right for
Breast Cancer
Sanofi 10
Large-scale testing (Phase 3)Study completedNCT01626222
What this trial is testing

4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 301
Testing effectiveness (Phase 2)WithdrawnNCT00057993
What this trial is testing

Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Large-scale testing (Phase 3)UnknownNCT02383030
What this trial is testing

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 156
Not applicableStudy completedNCT00814034
What this trial is testing

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

Who this might be right for
Breast Cancer
Hellenic Breast Surgeons Society 306
Testing effectiveness (Phase 2)Ended earlyNCT00263198
What this trial is testing

PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Study completedNCT02049957
What this trial is testing

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Calithera Biosciences, Inc 118
Post-approval studies (Phase 4)Study completedNCT00688909
What this trial is testing

Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 261
Testing effectiveness (Phase 2)Study completedNCT02694809
What this trial is testing

The PROMISE Study: Duavee in Women With DCIS

Who this might be right for
Ductal Breast Carcinoma In SituPostmenopausal
Northwestern University 142
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Testing effectiveness (Phase 2)Study completedNCT00634634
What this trial is testing

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Rutgers, The State University of New Jersey 52
Testing effectiveness (Phase 2)Ended earlyNCT00774878
What this trial is testing

Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 18
Not applicableStudy completedNCT01144572
What this trial is testing

Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment

Who this might be right for
Breast Cancer
AstraZeneca 494
Not applicableNot Yet RecruitingNCT07098507
What this trial is testing

De-escalation in Axillary Surgery for Early-stage Breast Cancer

Who this might be right for
Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer
Clinical Hospital Center Rijeka 620
Large-scale testing (Phase 3)UnknownNCT00003418
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

Who this might be right for
Breast Cancer
International Collaborative Cancer Group 4,400
Testing effectiveness (Phase 2)Study completedNCT04542135
What this trial is testing

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Alison Stopeck 62
Testing effectiveness (Phase 2)Study completedNCT00201864
What this trial is testing

Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00534417
What this trial is testing

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Accelerated Community Oncology Research Network 41
Large-scale testing (Phase 3)Study completedNCT00171340
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Who this might be right for
Bone LossBreast Cancer
Novartis Pharmaceuticals 1,065
Early research (Phase 1)Study completedNCT01808040
What this trial is testing

A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer

Who this might be right for
Post Menopausal, Hormone Receptor Positive Breast Cancer
University of Wisconsin, Madison 8
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation